NIGP 89810: Chemicals, Developing and Processing

NIGP 89810 Chemicals, Developing And Processing, an Item code, covers occupational medical surveillance and related diagnostic services that state and local governments procure to monitor worker health and regulatory compliance across hazardous occupations. State and local purchasing under this code spans health and safety program support for transportation, industrial, and public-sector workforces, including baseline and periodic medical examinations, occupational health testing, and regulatory-aligned medical record management. Issuing bodies include state transportation departments and their subordinate agencies. The work requires licensed medical professionals, typically physicians board-certified in occupational medicine, and often involves multi-site service delivery coordinated across geographically dispersed locations to accommodate workforce scheduling and regulatory notification timelines.

Washington State Department of Transportation, on behalf of the Washington State Ferries, posted RFP 20260825 on August 25, 2026, requesting occupational medical surveillance services with proposals due October 9, 2026. The scope includes baseline, periodic, follow-up, and exit medical examinations for four employee categories—Shipyard Workers, Engine Crew, Deck Crew, and Asbestos Team members—conducted across 14 Washington ferry locations (Anacortes, Bainbridge Island, Bremerton, Clinton, Coupeville, Edmonds, Kingston, Mukilteo, Port Orchard, Port Townsend, San Juan Islands, Seattle, Tacoma, and Vashon Island). Examinations must be delivered within 60 days of scheduling, with medical records provided to employees within 15 calendar days per Washington Administrative Code Chapter 296-802 and HIPAA compliance required. The contract term is two years with options to extend for up to five additional one-year terms. Evaluation weights pricing at 40 percent and non-cost capability factors at 60 percent, with a pre-bid conference held August 31, 2026, questions due September 7, and apparent-successful-bidder announcement scheduled for October 20, 2026.